GATC Biotech first in Europe to order Illumina's HiSeq 2000 gene
11 February 2010
GATC Biotech has purchased Illumina’s new HiSeq 2000 gene
sequencing platform, which was officially launched in January. This
latest acquisition will further strengthen GATC Biotech’s current fleet
of three GA IIx.
Initially, the company will employ the HiSeq 2000 for human genome
sequencing projects from its customers in the pharmaceutical and medical
It will also make the system’s high data output available to the
industrial and academic research community interested in the high
throughput sequencing of larger eukaryotic genomes.
“Illumina’s HiSeq 2000 with the estimated output of 200 GB per run
allows us to virtually sequence 60 human genomes at 1x coverage in a
week. Being an Illumina CSPro certified service provider we are
confident to have the system quickly installed and geared up for
production,” says Peter Pohl, CEO of GATC Biotech.
The HiSeq 2000 sequencing system had just been launched by llumina
Inc. on the occasion of the J.P. Morgan Healthcare Conference last week
in San Diego.